Find participating medical centers and current study status in each of them

    Find participating medical centers

    A clinical trial to compare the safety and effectiveness of ipatasertib plus palbociclib and fulvestrant versus a placebo plus palbociclib and fulvestrant in people with breast cancer

    A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

    • Cancer
    • Breast Cancer
    • Breast Cancer Er-Positive